Your browser doesn't support javascript.
loading
Pre-existing Fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation.
Chiu, Hsiao-Ying; Sun, Guang-Huan; Chen, Shiow-Yi; Wang, Hsiao-Hsien; Ho, Ming-Yi; Chu, Chia-Yi; Wu, Wan-Lin; Jhou, Ren-Shiang; Tsai, Yi-Lin; Huang, Rui-Ting; Sun, Kuang-Hui; Tang, Shye-Jye.
Afiliación
  • Chiu HY; Institute of Bioscience and Biotechnology and Center of Excellence for Marine Bioenvironment and Biotechnology (CMBB), National Taiwan Ocean University, Keelung, Taiwan, ROC.
Mol Carcinog ; 52(9): 705-14, 2013 Sep.
Article en En | MEDLINE | ID: mdl-22488710

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Melanoma Experimental / Transformación Celular Neoplásica / Proteína Ligando Fas / Microambiente Tumoral Límite: Animals / Humans / Male Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2013 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Melanoma Experimental / Transformación Celular Neoplásica / Proteína Ligando Fas / Microambiente Tumoral Límite: Animals / Humans / Male Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2013 Tipo del documento: Article